Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of MHB046C Injection in Patients With Advanced Solid Tumors — Stella

Home/Advanced Solid Cancer/A Study of MHB046C Injection in Patients With Advanced Solid Tumors

View on ClinicalTrials.gov

Recruiting

Back to Advanced Solid Cancer trials

A Study of MHB046C Injection in Patients With Advanced Solid Tumors

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Guangdong Provincial People's Hospital, Guangzhou, Guangdong

Key details

Phase

Early testing / Safety & dosing

Sponsor

Minghui Pharmaceutical (Hangzhou) Ltd

Enrollment target

~200 participants

Started

July 2025

Primary completion

May 2029

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.